Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a new study.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200609130006.htm
No comments:
Post a Comment